What's Driving the In Vitro Diagnostics Industry through 2020 and Beyond?--Alternative Scenarios of the Future IVD Market: Business-as-Usual, Economic Austerity, Technological Breakthroughs

Publisher Name :
Date: 10-Oct-2016
No. of pages: 255

This new report is designed to help executives develop effective contingency plans that best accommodate uncertainties ahead. The study objectives include:

  • To identify and evaluate emerging markets and technologies that may present unexpected threats or offer opportunities.
  • To identify key strategic decisions that will have to be made in the future.
  • To enhance corporate ability to develop realistic contingency plans.
  • To prepare executives to accommodate radically different operating climates and reduce surprises.
  • To challenge accepted perceptions of the future diagnostics market.
  • This report is an invaluable strategic planning resource for corporate, marketing and R&D executives. The strategic issues explored in the report include:

    - How will the future reimbursement changes affect individual market segments?

    - Will the industry consolidate, decentralize, or undergo a bimodal transformation?

    - What will be the impact on purchasing influences, marketing strategies, joint ventures, mergers,

    licensing, import and export?

    - How will the future technological advances affect the major market segment?

    - Which companies will enter the market and which will not survive?

    These and other key issues facing the decision-makers are explored in this thought-provoking and multi-faceted portrait of the three possible futures and their strategic implication. We would be glad to answer any questions you might have regarding this informative, comprehensive and insightful market research and technology assessment report, and look forward to your subscription.

    Contains 255 pages and 32 tables

     

    What's Driving the In Vitro Diagnostics Industry through 2020 and Beyond?--Alternative Scenarios of the Future IVD Market: Business-as-Usual, Economic Austerity, Technological Breakthroughs

    Table of Contents

    Recommendations
    IV.The Scenarios
    A. Business-As-Usual Scenario
    1. Business Environment
    a. Health Care Expenditures
    b. Cost-Consciousness
    c. Reimbursement
    d. Industry Consolidation
    e. Managed Care
    - PPOs
    - HMOs
    f. Hospitals
    g. Admissions
    h. Length of Stay
    i. Industry Diversification
    j. Physician Demographics
    k. Aging Population
    - Chronic Illnesses
    - Disease Incidence
    - Susceptibility to Iatrogenesis
    - Multiple Illness Cases
    l. Laboratory Regulations
    m. The FDA Reform
    2. Outlook for the In Vitro Diagnostics Market
    a. Government Regulations
    b. Centralized Testing
    - Hospitals
    - Commercial Laboratories
    - Blood Banks
    - Public Health Laboratories
    c. Decentralized Testing
    - Personal Testing
    - Physician Offices/Group Practices - Ancillary Hospital Locations
    - ERs
    - ORs
    - ICUs/CCUs
    - Cancer Clinics
    - Ambulatory Care Centers - Surgery Centers - Nursing Homes - Birth Centers 3. Strategic Implications
    a. Testing Patterns
    - Test Utilization
    - Pre-Admission Testing
    - Inpatient Testing
    - Outpatient Testing
    4. Market Segments
    a. Chemistry and Immunoassay
    - Introduction
    - Future Situation
    b. Microbiology and Serology
    - Introduction
    - Future Situation
    c. Hematology and Flow Cytometry
    - Introduction
    - Future Situation
    d. Histology and Cytology
    - Introduction
    - Future Situation
    e. Coagulation
    - Introduction
    - Future Situation
    f. Urinalysis
    - Introduction
    - Future Situation
    g. Blood Banking
    - Introduction
    - Future Situation
    5.Technologies
    a. Genomics
    - Introduction
    - Future Situation
    b. Proteomics
    - Introduction
    - Future Situation
    c. DNA Probes
    - Introduction
    - Future Situation
    d. Biochips/Microarrays
    - Introduction
    - Future Situation
    e. Monoclonal Antibodies
    - Introduction
    - Future Situation
    f. Solid Phase Chemistry
    - Introduction
    - Future Situation
    g. Biosensors
    - Introduction
    - Future Situation
    h. Automation and Robotics
    - Introduction
    - Future Situation
    i. Computer-Aided Diagnosis
    - Introduction
    - Future Situation
    6.The New Marketplace
    a. Purchasing Influences
    b. Marketing Strategies
    c. Joint Ventures, Mergers and Licensing
    d. Import-Export
    e. Potential Market Entrants
    f. Who May Not Survive?
    B. Economic Austerity Scenario
    1. Business Environment
    a. Socio-Political Climate
    - Cost-Consciousness
    - Government Actions
    - Three-Tier System
    - Health Rationing
    - Voucher System
    - Health IRA
    b. Hospital Closures
    c. Hospital Utilization
    d. Hospital Reorganization
    e. Physician Regulations
    f. Wellness Programs
    g. Corporate Responses
    h. Academic Research
    2. Outlook for the In Vitro Diagnostics Market
    a. Test Utilization
    - Ordering Practices
    - Documentation
    - Recertification
    b.Technology Regulations
    c. New Laboratory Ventures
    d. Computers
    e. Industrial Medicine
    f. Insurance Companies
    g. Test Volume and Market Size
    3. Strategic Implications
    a. Testing Patterns
    - Pre-Admission Testing
    - Inpatient Testing
    - Outpatient Testing
    b. Market Segments
    - Chemistry and Immunoassay
    - Microbiology and Serology
    - Hematology and Flow Cytometry
    - Histology and Cytology
    - Coagulation
    - Urinalysis
    - Blood Banking
    c.Technologies
    - Genomics
    - Proteomics
    - DNA Probes
    - Biochips/Microarrays
    - Monoclonal Antibodies and Immunoassays
    - Automation and Robotics
    - Solid Phase Chemistry
    - Biosensors
    - Computer-Aided Diagnosis
    d.The New Marketplace
    - Purchasing Influences
    - Marketing Strategies
    - Joint Ventures, Mergers and Licensing
    - Import-Export
    - Potential Market Entrants
    - Who May Not Survive?
    C.Technological Breakthroughs Scenario
    1. Business Environment
    a. Political/Regulatory Climate
    b. R & D Funding
    c. Industry-Government Relationship
    d. Industry-University Ventures
    e.Technological Environment
    f. Testing Decentralization
    g. Health Care Expenditures
    h. Physician Population
    i. Hospital Indicators
    2. Outlook for the In Vitro Diagnostics Market
    a. Overview
    b. Genomics
    c. Proteomics
    d. DNA and RNA Probes
    e. Biochips/Microarrays
    f. Monoclonal Antibodies
    g. Immunoassays
    h. Information Technology
    i. Laboratory Automation and Robotics
    j. Solid Phase Chemistry
    k. Biosensors
    l. Holography
    m. Pharmaceuticals
    3. Strategic Implications
    a.Testing Patterns
    - Pre-Admission Testing
    - Inpatient Testing
    - Outpatient Testing
    - Test Volume and Market Size
    b. Market Segments
    - Chemistry and Immunoassay
    - Microbiology and Serology
    - Hematology and Flow Cytometry
    - Histology and Cytology
    - Coagulation
    - Urinalysis
    - Blood Banking
    c.The New Marketplace
    - Purchasing Influences
    - Marketing Strategies
    - Joint Ventures, Mergers and Licensing
    - Import-Export
    - Potential Market Entrants
    - Who May Not Survive?
    V. Appendices: Methodology
    A.The Delphi
    B. Cross-Impact Analysis
    C. Substitution Modeling

    List of Tables

    Executive Summary Table I: Business-As-Usual Scenario, Growth Areas in Clinical Laboratory Testing
    Executive Summary Table II: Economic Austerity Scenario, Growth Areas in Clinical Laboratory Testing
    Executive Summary Table III: Technological Breakthroughs Scenario, Growth Areas in Clinical Laboratory Testing
    Executive Summary Table IV: Market Size by Location
    Executive Summary Table V: Market Size by Laboratory Discipline
    Table-1: Business-As-Usual Scenario, Health Care Costs by Expenditure Type
    Table-2: Business-As-Usual Scenario, HMO and PPO Enrollment
    Table-3: Business-As-Usual Scenario, Selected Hospital Statistics
    Table-4: Business-As-Usual Scenario,Total Population and Physician Demographics
    Table-5: Business-As-Usual Scenario,Test Volume by Location
    Table-6: Business-As-Usual Scenario,Test Distribution by Location
    Table-7: Business-As-Usual Scenario, Market Size by Location
    Table-8: Business-As-Usual Scenario,Typical Pre-Admission Tests
    Table-9: Business-As-Usual Scenario,Test Volume by Laboratory Discipline
    Table-10: Business-As-Usual Scenario, Market Size by Laboratory Discipline
    Table-11: Economic Austerity Scenario, Selected Hospital Statistics
    Table-12: Economic Austerity Scenario, HMO and PPO Enrollment
    Table-13: Economic Austerity Scenario,Total Population and Physician Demographics
    Table-14: Economic Austerity Scenario, Major Categories of Overutilized Tests
    Table-15: Economic Austerity Scenario, Test Volume by Location
    Table-16: Economic Austerity Scenario,Test Distribution by Location
    Table-17: Economic Austerity Scenario, Market Size by Location
    Table-18: Economic Austerity Scenario,Timing Requirements for Selected Laboratory Tests
    Table-19: Economic Austerity Scenario,Test Volume by Laboratory Discipline
    Table-20: Economic Austerity Scenario, Market Size by Laboratory Discipline
    Table-21: Technological Breakthroughs Scenario, HMO and PPO Enrollment
    Table-22: Technological Breakthroughs Scenario,Total Population and Physician Demographics
    Table-23: Technological Breakthroughs Scenario, Selected Hospital Statistics
    Table-24: Technological Breakthroughs Scenario, Test Volume by Location
    Table-25: Technological Breakthroughs Scenario, Test Distribution by Location
    Table-26: Technological Breakthroughs Scenario, Market Size by Location
    Table-27: Technological Breakthroughs Scenario, Test Volume by Laboratory Discipline
    Table-28: Technological Breakthroughs Scenario, Market Size by Laboratory Discipline
    • Renewable Energy Sources Needs To Boost Global Microgrids Market
      The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
    • Manufacturing Trends In The Coming Days
      The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
    • Top 10 Emerging Technologies
      The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
    • Global Biosimilars Market To Be Led By Novartis by 2020
      Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
    • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
      The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • In Vitro Diagnostics Industry Forecasts - China Focus
    Published: 15-May-2017        Price: US 1800 Onwards        Pages: 94
    This study focuses on China's In Vitro Diagnostics industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services......
  • In Vitro Diagnostics Companies in China
    Published: 15-May-2017        Price: US 1800 Onwards        Pages: 52
    This study focuses on China's In Vitro Diagnostics industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumption......
  • China In-Vitro Diagnostics (IVD) Market, Forecast, Companies Analysis, Registration Rules
    Published: 15-May-2017        Price: US 1500 Onwards        Pages: 101
    China In-vitro diagnostics market is expected to be triple its market size by the end of 2022 from its market size in 2016. China In-Vitro Diagnostics sector is expected to grow with a double digit CAGR of 19.01% in future. With such a huge growth rate China is poised to become the world’s largest In–vitro Diagnostics (IVD) Market in the next few years for both domestic and foreign IVD products. The In–Vitro Diagnostics (IVD) Market in China has been growing rapidly over the......
  • In Vitro Diagnostics Markets in China
    Published: 15-May-2017        Price: US 4000 Onwards        Pages: 198
    China's demand for In Vitro Diagnostics has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, ......
  • IVD Market in China 2017-2021
    Published: 10-May-2017        Price: US 3500 Onwards        Pages: 70
    IVD procedures are conducted outside of a living organism in a test tube, petri dish, or culture dish. Whereas, in vivo diagnostics are carried out inside a living organism. IVD products are intended to collect biological samples such as blood, sputum, urine, spinal fluid, and DNA from a patient's body. They are analyzed in hospitals, clinics, and laboratories. IVD products are reagents and instruments that help in the diagnosis of diseases. The analysts forecast in-vitro diagnostics ......
  • Global Women's Health Diagnostics Market 2017-2021
    Published: 10-May-2017        Price: US 3500 Onwards        Pages: 70
    Technological advances such as integration of digital technology with diagnostic instrumentation, multiple technologies-based hematology analyzers, and quick monitoring of blood flow in deep tissues with real-time software correlators are boosting the growth of the IVD instruments market. The growing popularity of automation and technological advances have led to new product development user-friendly diagnostic instruments for laboratories and physician offices, as well as home-care settings.......
  • IVD Market in BRIC by Product & Service (Instruments, Reagents, Software), Technology (Immunoassay, Hematology, Microbiology), Application (Diabetes, Cardiology, Infectious Diseases), Country (Brazil, Russia, India, China) - Forecast to 2022
    Published: 08-May-2017        Price: US 5650 Onwards        Pages: 278
    The IVD market in BRIC is expected to reach USD 15.71 billion by 2022 from USD 10.60 billion in 2017, at a CAGR of 8.2%. The key factors driving the growth of the market are growing patient awareness of personalized medicine, increasing prevalence of lifestyle and chronic diseases, growth in the number of private diagnostic centers, and improving healthcare system in emerging countries. However, market growth is restrained by the lack of reimbursement and the slow growth of the economy in som......
  • Global In Vitro Diagnostics Partnering 2010-2017: Deal trends, players, financials and forecasts
    Published: 01-Apr-2017        Price: US 2995 Onwards        Pages: 660
    "Delivery of this report will take 1-3 days after purchase." Global In Vitro Diagnostics Partnering 2010-2017 report provides comprehensive understanding and unprecedented access to the in vitro diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies The Global In Vitro Diagnostics Partnering 2010-2017 report provides a detailed understanding and analysis of how and why companies enter in vitro diagnostics partnering deals......
  • 2017 World Virology and Bacteriology Testing Market: Future Horizons and Growth Strategies--Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities by Test
    Published: 21-Mar-2017        Price: US 34500 Onwards        Pages: 1900
    Complete report $34,500. DataPack (test volumes, sales forecasts, supplier shares) $21,100. VPGMarketResearch.com's new report is a seven-country strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key trends in the U.S., five major European countries (France, Germany, Italy, Japan, UK) and Japan; reviews current and emerging assays; analyzes potential ap......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs